Then, a full-text review of 209 articles further excluded 179 studies, of which 108 were unrelated to the topic of this study, 19 had no data on fetuin-A and fetuin-B, 35 did not report means and SDs of fetuin-A and fetuin-B concentrations, 8 did not compare fetuin-A and fetuin-B concentrations between NAFLD patients and a control group, 3 were reviews, and 6 did not report the results of a control group. This evidence concerns the gene FETUB and metabolic dysfunction-associated steatotic liver disease.